Frederick Derheimer, III is a seasoned professional in the fields of drug discovery and biological research, currently serving as the Senior Director of Drug Discovery Biology at Boundless Bio since January 2024. With a robust career at Pfizer from August 2015 to January 2024, Frederick held multiple titles, including Associate Research Fellow and Principal Scientist. In addition, Frederick contributed as a member of the IBM Watson for Drug Discovery Innovation Council from March 2018 to March 2019, providing expertise in AI and machine learning applications in healthcare. Earlier experience includes postdoctoral fellowships at Eli Lilly and Company and St. Jude Children's Research Hospital, where Frederick developed protocols for DNA repair studies. Academic foundations were laid with a Ph.D. in Cellular and Molecular Biology from the University of Michigan and a BS in Biology from Indiana University Bloomington.
This person is not in the org chart
This person is not in any teams
This person is not in any offices